OpenFilings

REGENERON PHARMACEUTICALS, INC.

Form10-K

Report Period2024-12-31

Date Filed2025-02-05

Time Filed09:18:14

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
DESCRIPTION OF SECURITIES
AMENDMENT AGREEMENT, DATED DECEMBER 30, 2014 BETWEEN BAYER AND REGISTRANT
INSIDER TRADING POLICY
SUBSIDIARIES OF THE REGISTRANT
CONSENT OF PRICEWATERHOUSECOOPERS LLP
CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
Filing on SEC Edgar